Literature DB >> 31918269

New sights in cancer: Component and function of N6-methyladenosine modification.

Yiyang Hu1, Sumin Wang1, Jiao Liu2, Yu Huang1, Chunli Gong1, Jingjing Liu1, Yufeng Xiao3, Shiming Yang4.   

Abstract

M6A is the most prevalent modification among epigenetics. M6A occurs on different sites of RNA and exerts important functions in specific circumstances, such as mRNA splicing, stability, nuclear export, translation or damage response. Different aspects of the concrete machinery of m6A modification have been studied, including its writing, erasing and reading capabilities. The molecular and biological functions of the m6A modification and enzymes, as well as their functions in different cancers have been substantially published. The present review summarizes these findings and provides clear description of the problems involved. The probable roles of m6A modification may acts on other cancers, suggesting that it may be a treatment target for these cancers.
Copyright © 2019 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  Cancer therapy; Human cancers; N(6)-methyladenosine; RNA methylation; m(6)A

Mesh:

Substances:

Year:  2019        PMID: 31918269     DOI: 10.1016/j.biopha.2019.109694

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  6 in total

1.  Novel Small Molecule RNA m6A Demethylase AlkBH5 Inhibitors for Treating Cancer.

Authors:  Ram W Sabnis
Journal:  ACS Med Chem Lett       Date:  2021-05-19       Impact factor: 4.632

2.  Improved Synthesis of Phosphoramidite-Protected N6-Methyladenosine via BOP-Mediated SNAr Reaction.

Authors:  Shifali Shishodia; Christopher J Schofield
Journal:  Molecules       Date:  2020-12-31       Impact factor: 4.411

3.  FTO demethylates m6A modifications in HOXB13 mRNA and promotes endometrial cancer metastasis by activating the WNT signalling pathway.

Authors:  Lin Zhang; Yicong Wan; Zihan Zhang; Yi Jiang; Jinghe Lang; Wenjun Cheng; Lan Zhu
Journal:  RNA Biol       Date:  2020-11-05       Impact factor: 4.652

4.  Comprehensive Analysis of the Transcriptome-Wide m6A Methylome in Pterygium by MeRIP Sequencing.

Authors:  Yaping Jiang; Xin Zhang; Xiaoyan Zhang; Kun Zhao; Jing Zhang; Chuanxi Yang; Yihui Chen
Journal:  Front Cell Dev Biol       Date:  2021-06-25

5.  The m6A epitranscriptome opens a new charter in immune system logic.

Authors:  Zhonghua Ma; Xiangyu Gao; You Shuai; Xiaofang Xing; Jiafu Ji
Journal:  Epigenetics       Date:  2020-10-19       Impact factor: 4.861

6.  A newly defined risk signature, consisting of three m6A RNA methylation regulators, predicts the prognosis of ovarian cancer.

Authors:  Lili Fan; Ying Lin; Han Lei; Guang Shu; Liuer He; Zhipeng Yan; Hai Rihan; Gang Yin
Journal:  Aging (Albany NY)       Date:  2020-09-20       Impact factor: 5.682

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.